Which rationale best explains choosing a third-generation cephalosporin in empiric therapy for early-onset sepsis with meningitis risk or local resistance?

Which rationale best explains choosing a third-generation cephalosporin in empiric therapy for early-onset sepsis with meningitis risk or local resistance?

• A. Coverage for meningitis due to better CNS penetration than gentamicin
• B. It is cheaper than gentamicin
• C. It has less resistance than gentamicin
• D. It is more nephrotoxic than gentamicin

Answer: (A)

The main idea here is ensuring the drug reaches the central nervous system effectively when there is a risk of meningitis. A third-generation cephalosporin achieves reliable concentrations in the cerebrospinal fluid, providing robust coverage against common neonatal meningitis pathogens. Gentamicin, by contrast, has limited CSF penetration unless the meninges are inflamed, so it may not adequately treat meningitis if that risk is present. In this empiric scenario, you want a drug that can reliably reach the CNS to control potential meningitis, and that’s why a third-generation cephalosporin is favored. Other points like cost or general resistance patterns are less decisive here, and third-generation cephalosporins are less nephrotoxic than gentamicin.

The main idea here is ensuring the drug reaches the central nervous system effectively when there is a risk of meningitis. A third-generation cephalosporin achieves reliable concentrations in the cerebrospinal fluid, providing robust coverage against common neonatal meningitis pathogens. Gentamicin, by contrast, has limited CSF penetration unless the meninges are inflamed, so it may not adequately treat meningitis if that risk is present. In this empiric scenario, you want a drug that can reliably reach the CNS to control potential meningitis, and that’s why a third-generation cephalosporin is favored. Other points like cost or general resistance patterns are less decisive here, and third-generation cephalosporins are less nephrotoxic than gentamicin.